http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28245099

Outgoing Links

Predicate Object
contentType Journal Article
issn 1479-5876
issueIdentifier 1
pageRange 115-
publicationName Journal of Translational Medicine
startingPage 115
bibliographicCitation Guida M, Cramarossa A, Fistola E, Porcelli M, Giudice G, Lubello K, Colucci G. High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study. Journal of Translational Medicine. 2010 Nov 10;8(1):115. doi: 10.1186/1479-5876-8-115.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34dec95750fbd2c18dca26a52ab5deea
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75c0638612062e78b606eaa7218ad260
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c64e7e53011960fc8a9b804040f78df0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1217de1ef48070530b81121aa23fdec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd2f41ba3e58df9656005dcf5864a4e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a74db5f701bebbc9913659e558b702f8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_329553e0299a81d59e8079888c965b42
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8411-0319
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6606-1760
date 2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/1479-5876-8-115
https://pubmed.ncbi.nlm.nih.gov/PMC2992498
https://pubmed.ncbi.nlm.nih.gov/21067582
isPartOf https://portal.issn.org/resource/ISSN/1479-5876
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31680
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study
discusses http://id.nlm.nih.gov/mesh/M0015421
http://id.nlm.nih.gov/mesh/M0153576
http://id.nlm.nih.gov/mesh/M0005636
http://id.nlm.nih.gov/mesh/M0136562
http://id.nlm.nih.gov/mesh/M0014925
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128760415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127495371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127993436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127739631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135758261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127830723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128334455

Total number of triples: 45.